Summit Therapeutics, Inc. (SMMT)
Summit Therapeutics Market Cap : 14.58B for April 8, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| BioMarin Pharmaceutical, Inc. | 11.00B |
| Eli Lilly & Co. | 851.64B |
| Revolution Medicines, Inc. | 19.17B |
| Exelixis, Inc. | 11.48B |
| Insmed, Inc. | 34.53B |
Market Cap Related Metrics
| PEG Ratio | -0.0352 |
| Price to Book Value | 22.14 |
| Price | 18.81 |
| Earnings Yield | -7.68% |
| PEGY Ratio | -0.0352 |